Vancouver Biotech Limited
Biotech Research, Development and Proprietary Technologies
About Us
For more than 30 years, Vancouver Biotech Limited (VBL) has conducted biotech research and development, creating several proprietary technologies. These intellectual properties have been primarily focused on monoclonal antibodies (MABs), including methodologies for the generation of MABs and the development of patented MABs.
These MABs have potential application in the immunodiagnostic and immunotherapy of human diseases and health conditions, including cancer and fertility regulation. VBL’s previous immunodiagnostic work included early pregnancy, ovulation, as well as menopause tests, among others.
Our Mission
The mission of Vancouver Biotech Limited is to develop innovative monoclonal antibodies for immunodiagnostic products and medical devices for the therapeutic treatment of human diseases and health conditions.
Company History
VBL was founded in 1988 in Vancouver, Canada by Dr. Gregory Lee. VBL was under a royalty agreement with The University of British Columbia (concluded in 2018), where Dr. Lee was a tenured professor in the Faculty of Medicine, Department of Obstetrics & Gynaecology for 31 years. Dr. Lee holds a B.Sc. in Chemistry/Physical Biochemistry from National Taiwan University, Taiwan and a M.Sc. and Ph.D. in Chemistry from the California Institute of Technology, USA.
VBL’s Current Work
Anti-human Cardiac Troponin I (TPC110)
Immunotherapeutic Applications of RP215 MAB for Cancer Treatment
Immunodiagnostic Applications of CA215 as Pan-Cancer Biomarker for Cancer Monitoring
Immunotherapeutic Applications of GHR106 MABs for Cancer Treatment
GHR106 MAB as Bioequivalent Drugs for Fertility Regulation & Control
Our Team
Gregory CY Lee, PhD
President & Founder
- Emeritus Professor, Faculty of Medicine, Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, BC, Canada
- PhD, Chemistry, California Institute of Technology, Pasadena, CA, USA
- 30+ Years Research & Development Experience
- 206 scientific publications
- 10 Patents
Matthew A. Wong, PhD
Business Manager
- Lecturer, Faculty of Applied Science & The Sauder School of Business, University of British Columbia, Vancouver, BC, Canada
- PhD, General Management (Entrepreneurship), Ivey Business School, Western University, London, ON, Canada
- 7 Years Education and Consulting Experience
- 7 Published business cases with Ivey Publishing
©2021 - Vancouver Biotech Limited. All Rights Reserved.